In the present study, it was demonstrated that SU5416, a tyrosine kinase inhibitor of VEGFR2, not only blocks tumor cell-stimulated angiogenesis but also eliminates alcohol-mediated promotion of tumor angiogenesis (Fig. 3). Here, KDR is linked to neoplasm.